• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Harrow Inc (NQ: HROW )

    20.93 -0.12 (-0.57%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,867
    Open 20.93
    Bid (Size) 20.65 (4)
    Ask (Size) 21.11 (4)
    Prev. Close 21.05
    Today's Range 20.93 - 20.93
    52wk Range 7.600 - 22.63
    Shares Outstanding 35,382
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
    Via Benzinga

    Performance

    YTD
    +75.15%
    +75.15%
    1 Month
    +22.90%
    +22.90%
    3 Month
    +63.52%
    +63.52%
    6 Month
    +75.15%
    +75.15%
    1 Year
    +14.03%
    +14.03%

    More News

    Read More
    Insiders Buying Greenwich LifeSciences And 2 Other Stocks
    Via Benzinga
    Harrow Provides TRIESENCE® Relaunch Update
    From Harrow, Inc.
    Via Business Wire
    The Top 7 Growth Stocks to Buy and Hold Until 2030
    Via InvestorPlace
    Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
    From Melt Pharmaceuticals, Inc.
    Via Business Wire
    Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
    From Harrow, Inc.
    Via Business Wire
    3 Stocks Insiders are Buying That Should be on Your Radar
    Via MarketBeat
    Harrow to Present at Two Investor Conferences in May
    From Harrow, Inc.
    Via Business Wire
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Harrow Announces First Quarter 2024 Financial Results
    From Harrow, Inc.
    Via Business Wire
    Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
    From Harrow, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
    From Harrow, Inc.
    Via Business Wire
    Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
    From Melt Pharmaceuticals, Inc.
    Via Business Wire
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
    Via InvestorPlace
    Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.